PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
8.60%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
69.00%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
69.00%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
36.42%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while UPM.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while UPM.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
13.68%
Share change of 13.68% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
13.68%
Diluted share change of 13.68% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-10.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
35.62%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-32.58%
Negative 10Y revenue/share CAGR while UPM.HE stands at 9.35%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-20.63%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
259.95%
Positive long-term OCF/share growth while UPM.HE is negative. John Neff would see a structural advantage in sustained cash generation.
117.57%
5Y OCF/share CAGR above 1.5x UPM.HE's 26.89%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
190.16%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
0.00%
Below 50% of UPM.HE's 164.63%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-33.33%
Negative 5Y net income/share CAGR while UPM.HE is 22.62%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-40.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
19.20%
Below 50% of UPM.HE's 41.85%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
24.65%
5Y equity/share CAGR is in line with UPM.HE's 22.43%. Walter Schloss would see parallel mid-term profitability and retention policies.
18.48%
3Y equity/share CAGR similar to UPM.HE's 19.98%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-100.00%
Cut dividends over 10 years while UPM.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.35%
Firm’s AR is declining while UPM.HE shows 35.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.98%
Inventory is declining while UPM.HE stands at 3.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.79%
Negative asset growth while UPM.HE invests at 1.56%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.40%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.07%
We’re deleveraging while UPM.HE stands at 3.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-14.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.